Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

Magnificent Seven stocks. Big Tech's runaway growth created gains, but headwinds are forming and some observers doubt the Mag ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Merck & Co., Inc.

Upcoming patent expirations are driving pharmaceutical companies to acquire in 2025. In Sweden, we may be on our way to ...